Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

NCT04461457 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ovarian Cancer

Interventions

COMBINATION_PRODUCT: 211-astatine MX35 F(ab')2

Sponsor

Vastra Gotaland Region

Collaborators

[object Object]
[object Object]
[object Object]